Changes of rho kinase activity after hemorrhagic shock and its role in shock-induced biphasic response of vascular reactivity and calcium sensitivity

Shock

Volumn 26, Issue 5, 2006, Pages 504-509

  Li, Tao ^a   Liu, Liangming ^a   Xu, Jing ^a   Yang, Guangming ^a   Ming, Jia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Calcium sensitivity; Hemorrhagic shock; Insulin; Rho kinase activity; Vascular reactivity; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; CALCIUM; INSULIN; NORADRENALIN; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DEPOLARIZATION; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMORRHAGIC SHOCK; NONHUMAN; ORGAN PERFUSION; RAT; SUPERIOR MESENTERIC ARTERY;

AMIDES; ANGIOTENSINS; ANIMALS; CALCIUM; ENZYME INHIBITORS; INSULIN; MESENTERIC ARTERY, SUPERIOR; MUSCLE, SMOOTH, VASCULAR; PYRIDINES; RATS; RATS, WISTAR; RHO GTP-BINDING PROTEINS; SHOCK, HEMORRHAGIC;

EID: 33750332693     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000228796.41044.41     Document Type: Article

References (24)

1. Liu LM, Ward JA, Dubick MA: Hemorrhagic shock induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock 19:208-214, 2003.
2. Liu LM, Dubick MA: Regional diversity of hemorrhagic shock-induced vascular hyporeactivity and the roles of nitric oxide and endothelin: relationship to gene expression of NO/ET-1 and select cytokines in corresponding organs. J Surg Res 125:128-136, 2005.
3. Zhao KS, Huang XL, Liu J, Huang Q, Jin C, Jiang Y, Jin J, Zhao G: New approach to treatment of shock-restitution of vasoreactivity. Shock 18:189-192, 2002.
4. + channels in mesenteric arterial smooth muscle cells of rats in hemorrhagic shock. Shock 19:85-99, 2003.
5. Mei JM, Hu DY, Chen HS, Liu LM, Xiao N, Chen HH, Lu RQ: Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats. Shock 14:652-656, 2000.
6. Xu J, Liu LM: The role of calcium desensitization in vascular hyporeactivity and its regulation following hemorrhagic shock. Shock 23:576-581, 2005.
7. Matsui T, Amano M, Yamamoto T, Chihara K, Natatuka M, Ito M, Nakano T, Okama K, Iwamastu A: Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15:2208-2216, 1996.
8. Kaibuchi K, Kuroda S, Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68:459-486, 1999.
9. Tostukawa G, Yamakita Y: Yamashiros: Distinct Roles of ROCK (Rho-kinase) and MLDK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150:797-806, 2000.
10. Van AL, Souza SC: Rho GTPase and signaling net works. Genes Dev 11:2295-2322, 1997.
11. Matsuoka Y, Hughes CA, Bennett V: Adducin regulation, definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C. J Biol Chem 271:25157-25166, 1996.
12. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T: Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274:37385-37390, 1999.
13. Begum N, Duddy N, Sandu O, Reinzie J, Ragolia L: Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphaticylinositol-3-kinase-dependent signaling pathways. Mol Endocrinol 114:1365-1376, 2000.
14. Buyukafsar K, Arikan O, Ark M, Secilmis A, Un I, Singirik E: Rho kinase expression and its contribution to the control of perfusion pressure in the isolated rat mesenteric vascular bed. Euro J Pharmacol 485(1-3):263-268, 2004.
15. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Iwamatsu A, Kaibuchi K, Hartshorne DJ, Nakano T: Rho associated kinase of chicken gizzard smooth muscle. J Biol Chem 274:3744-3752, 1999.
16. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GI: Modulation of hypoxia inducible factor expression by the epidermal growth factor PI3K/PTEN/AKT/FRAP pathway in human prostate cancer cell: implication for tumor angiogenesis therapeutics. Cancer Res 60:1541-1545, 2000.
17. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A: Active Rho kinase (ROK-α) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277:6214-6222, 2002.
18. 2-terminal kinase is mediated by Rac1 and Nck. J Biol Chem 276(25):22003-22010, 2001.
19. Burridge K, Wennerberg K: Rho and Rac take center stage. Cell 116(2):167-179, 2004.
20. Laufs U, Liao JK: Targeting Rho in cardiovascular disease. Circ Res 87:526-528, 2000.
21. Somlyo AP, Somlyo AV: Signal transduction by G protein, Rho kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177-185, 2000.
22. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997.
23. Begum N: Insulin signaling in the vasculature. Front Biosci 8:s796-s804, 2003.
24. Wang Z, Lanner MC, Jin N, Swartz D, Li L, Rhoade RA: Hypoxia inhibits myosin phosphatase in pulmonary arterial smooth muscle cells: role of Rhokinase. Am J Respir Cell Mol Biol 29:465-471, 2003.